Automation index
How much of a Renewables engineer’s job can AI already do?
A solar resource and a layout come earlier. Connecting the plant so it actually exports do not.
This percentage does not predict how many people will lose their jobs.
Task comparison
IS WORK OVER?
Renewables engineer
27%
AI can already do 27% of this job.
#165 / 643
View rankingRenewables engineer
Where the time goes
Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.
The time saving for each task is estimated separately.
| Task | Share | AI | Points |
|---|---|---|---|
Resource, layout and the yield model.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 48% | +8.6 |
Site, topography and the cable that will not reach.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 22% | +3.5 |
Permits, grid point and the TSO.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 36% | +5.8 |
EPC, commissioning and export tests.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 28% | +4.5 |
The neighbour, the council and the appeal against the plant.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 14% | +2.5 |
That it exports, and not inflating equivalent hours.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 12% | +1.9 |
| Total | 100% | 27% |
Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low
Skills and activities
- plant layout
- solar resource
- grid connection
- commissioning
- renewables permits
- yield model
- export tests
- EPC
Sources for this job· O*NET 17-2199.00· ESCO/ISCO 2149
IS WORK OVER?
Immunologist
27%
#168 / 643
View rankingImmunologist
Where the time goes
Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.
The time saving for each task is estimated separately.
| Task | Share | AI | Points |
|---|---|---|---|
Panel, autoantibodies and the report.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 48% | +8.6 |
Clinic, the flare and the one that does not fit.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 40% | +6.4 |
Immunosuppressant, the dose and not dropping extra.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 22% | +3.5 |
Infection, the risk and vaccinating on time.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 28% | +4.5 |
The internist, the board and not delaying the biologic.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 14% | +2.5 |
Call it autoimmune, and sign the treatment.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 12% | +1.9 |
| Total | 100% | 27% |
Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low
Skills and activities
- autoantibodies
- autoimmune flares
- immunosuppressants
- biologics
- vaccinate the immunocompromised
- immunology clinic
- opportunistic infections
- immune panels
Sources for this job· O*NET 29-1229.00· ESCO/ISCO 2212